<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Setazindol</id>
	<title>Setazindol - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Setazindol"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Setazindol&amp;action=history"/>
	<updated>2026-05-12T08:59:31Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Setazindol&amp;diff=5369209&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Setazindol&amp;diff=5369209&amp;oldid=prev"/>
		<updated>2024-03-06T05:01:46Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Setazindol.png|thumb|{{PAGENAME}}]]&amp;lt;br&amp;gt;&amp;#039;&amp;#039;&amp;#039;Setazindol&amp;#039;&amp;#039;&amp;#039; is a [[drug]] that was developed in the 1970s by the [[pharmaceutical industry]]. It is classified as an [[anorectic]], which means it is used to suppress or reduce [[appetite]]. Setazindol is part of a larger class of drugs known as [[stimulants]], which are substances that increase activity in the [[central nervous system]] and the body.&lt;br /&gt;
&lt;br /&gt;
== History ==&lt;br /&gt;
&lt;br /&gt;
Setazindol was first synthesized in the 1970s by the [[pharmaceutical company]] [[Hoffmann-La Roche]]. It was developed as part of a wave of new anorectic drugs that were being produced and marketed at the time. However, unlike many of its contemporaries, Setazindol was never widely used or commercially successful.&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
&lt;br /&gt;
As an anorectic, Setazindol works by suppressing the appetite. This is achieved by stimulating the release of certain [[chemicals]] in the brain that control feelings of hunger and fullness. Setazindol is also a stimulant, which means it increases activity in the central nervous system and the body. This can lead to increased [[heart rate]], [[blood pressure]], and [[metabolism]], among other effects.&lt;br /&gt;
&lt;br /&gt;
== Side Effects ==&lt;br /&gt;
&lt;br /&gt;
Like all drugs, Setazindol can have side effects. These can include [[insomnia]], [[nervousness]], [[irritability]], and [[dry mouth]]. In rare cases, it can also cause more serious side effects such as [[heart palpitations]], [[high blood pressure]], and [[psychosis]]. Due to these potential side effects, Setazindol is typically only prescribed for short-term use.&lt;br /&gt;
&lt;br /&gt;
== Legal Status ==&lt;br /&gt;
&lt;br /&gt;
Setazindol is a controlled substance in many countries, including the [[United States]], where it is classified as a [[Schedule IV controlled substance]]. This means it has a low potential for abuse and is available only by prescription.&lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
&lt;br /&gt;
* [[Anorectic]]&lt;br /&gt;
* [[Stimulant]]&lt;br /&gt;
* [[Hoffmann-La Roche]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Drugs]]&lt;br /&gt;
[[Category:Anorectics]]&lt;br /&gt;
[[Category:Stimulants]]&lt;br /&gt;
{{pharmacology-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>